Atticus Wealth Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
ATO
Atticus Wealth Management's MRK Position: Q2 2026 in Review
Atticus Wealth Management increased its Merck (MRK) stake by 0.98% in Q2 2026, buying an estimated $6.55K and bringing the position to 5,756 shares worth $740K. The position accounts for 0.18% of the portfolio, ranked #82.
Atticus Wealth Management first reported a position in MRK in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.56M in Q4 2019. 1,552 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Atticus Wealth Management held 5,756 shares of Merck worth $740K as of Q2 2026.
- Atticus Wealth Management bought 56 Merck shares in Q2 2026, an estimated $6.55K.
- Merck made up 0.18% of Atticus Wealth Management's portfolio in Q2 2026, its #82 holding.
- Atticus Wealth Management first reported a position in Merck in Q4 2019 and has held it in 27 quarters since.
- Atticus Wealth Management's Merck position peaked at $1.56M in Q4 2019.
- 1,552 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Atticus Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.